Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

ClinicalTrials.gov ID: NCT00569972

Public ClinicalTrials.gov record NCT00569972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PD 0200390 Dose Ranging Trial: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

Study identification

NCT ID
NCT00569972
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
682 participants

Conditions and interventions

Conditions

Interventions

  • PD 0200390 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Dec 31, 2008
Completion
Dec 31, 2008
Last update posted
Jul 24, 2012

2007 – 2009

United States locations

U.S. sites
71
U.S. states
23
U.S. cities
60
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35213
Pfizer Investigational Site Phoenix Arizona 85023
Pfizer Investigational Site Phoenix Arizona 85059
Pfizer Investigational Site Scottsdale Arizona 85254
Pfizer Investigational Site Tucson Arizona 85712
Pfizer Investigational Site Little Rock Arkansas 72205
Pfizer Investigational Site Encino California 91316
Pfizer Investigational Site Garden Grove California 92845
Pfizer Investigational Site Los Alamitos California 90720
Pfizer Investigational Site Newport Beach California 92660
Pfizer Investigational Site Redlands California 92374
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site San Diego California 92108
Pfizer Investigational Site San Diego California 92120
Pfizer Investigational Site Sherman Oaks California 91403
Pfizer Investigational Site Colorado Springs Colorado 80909
Pfizer Investigational Site Brooksville Florida 34613
Pfizer Investigational Site DeLand Florida 32720
Pfizer Investigational Site Hallandale Florida 330009
Pfizer Investigational Site Hallandale Florida 33009
Pfizer Investigational Site Jacksonville Florida 32216
Pfizer Investigational Site Jupiter Florida 33458
Pfizer Investigational Site Maitland Florida 32751
Pfizer Investigational Site Miami Florida 33143
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Pembroke Pines Florida 33026
Pfizer Investigational Site Spring Hill Florida 34609
Pfizer Investigational Site Tampa Florida 33609-4052
Pfizer Investigational Site Tampa Florida 33609
Pfizer Investigational Site Tampa Florida 33613
Pfizer Investigational Site Tampa Florida 33614
Pfizer Investigational Site Atlanta Georgia 30328
Pfizer Investigational Site Atlanta Georgia 30342
Pfizer Investigational Site Gainsville Georgia 30501
Pfizer Investigational Site Macon Georgia 31201
Pfizer Investigational Site Arlington Heights Illinois 60004
Pfizer Investigational Site Chicago Illinois 60607
Pfizer Investigational Site Chicago Illinois 60622
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Newburgh Indiana 47630
Pfizer Investigational Site Lexington Kentucky 40504
Pfizer Investigational Site Mount Sterling Kentucky 40353
Pfizer Investigational Site Mount Sterlingg Kentucky 40353
Pfizer Investigational Site Chevy Chase Maryland 20815
Pfizer Investigational Site Ann Arbor Michigan 48104
Pfizer Investigational Site Kalamazoo Michigan 49009
Pfizer Investigational Site Saint Clair Shores Michigan 48081
Pfizer Investigational Site Albuquerque New Mexico 87108
Pfizer Investigational Site New York New York 10019
Pfizer Investigational Site Staten Island New York 10312
Pfizer Investigational Site Charlotte North Carolina 28207
Pfizer Investigational Site Durham North Carolina 27710
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Cincinnati Ohio 45245
Pfizer Investigational Site Cleveland Ohio 44122
Pfizer Investigational Site Columbus Ohio 43213
Pfizer Investigational Site Dayton Ohio 45408
Pfizer Investigational Site Kettering Ohio 45429
Pfizer Investigational Site Toledo Ohio 43623
Pfizer Investigational Site Portland Oregon 97239
Pfizer Investigational Site East Providence Rhode Island 02914
Pfizer Investigational Site Charleston South Carolina 29407
Pfizer Investigational Site Memphis Tennessee 38117
Pfizer Investigational Site Austin Texas 78754
Pfizer Investigational Site Austin Texas 78756
Pfizer Investigational Site Dallas Texas 75230
Pfizer Investigational Site Houston Texas 77024
Pfizer Investigational Site Houston Texas 77063
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Newport News Virginia 23606
Pfizer Investigational Site Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00569972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00569972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →